Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

Diabetologia

Volumn 50, Issue 11, 2007, Pages 2323-2331

  Butler, A E ^a   Galasso, R ^a   Meier, J J ^a   Basu, R ^b   Rizza, R A ^b   Butler, P C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Apoptosis; Beta cell replication; Human; Islet degeneration and damage; Islets; Ketoacidosis; Prediction of type 1 diabetes; Prevention of type 1 diabetes; Recent onset type 1 diabetes

Indexed keywords

ACIDOSIS; APOPTOSIS; ARTICLE; AUTOPSY; CAUSE OF DEATH; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MORPHOMETRICS; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; APOPTOSIS; AUTOPSY; CELL DIVISION; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; PANCREAS; REFERENCE VALUES;

EID: 34848851427     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0794-x     Document Type: Article

References (28)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
2. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
3. Junker K, Egeberg J, Kromann H et al (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A 85:699-706
4. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251-261
5. Kloppel G, Drenck CR, Oberholzer M et al (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 403:441-452
6. Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-461
7. Lernmark A, Kloppel G, Stenger D et al (1995) Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631-640
8. Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762
9. Meier JJ, Bhushan A, Butler AE et al (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
10. Meier JJ, Lin JC, Butler AE et al (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838-1844
11. Allen FM (1922) Hydropic degeneration of islands of Langerhans after partial pancretectomy. J Metab Res 1:5-41
12. In't Veld P, Lievens D, De Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes DOI 10.2337/db07-0416
13. Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53:250-264
14. Tsai EB, Sherry NA, Palmer JP et al (2006) The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 49:261-270
15. Hramiak IM, Dupre J, Finegood DT (1993) Determinants of clinical remission in recent-onset IDDM. Diabetes Care 16:125-132
16. Karges B, Durinovic-Bello I, Heinze E et al (2004) Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment. Diabetes Care 27:1207-1208
17. Rasouli N, Elbein SC (2004) Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 89:6331-6335
18. Kumar D, Luna-Lollie T, Madha S (2001) One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes. Endocr Pract 7:256-261
19. Matveyenko AV, Veldhuis JD, Butler PC (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55:2347-2356
20. Ritzel RA, Butler AE, Rizza RA et al (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717-718
21. Federici M, Hribal M, Perego L et al (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290-1301
22. Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
23. Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437-1442
24. Meier JJ, Butler AE, Galasso R et al (2006) Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia 49:2689-2696
25. Stenstrom G, Gottsater A, Bakhtadze E et al (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68-S72
26. Robertson RP, Harmon JS (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41:177-184
27. Kahl CR, Means AR (2003) Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24:719-736
28. Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108-S113